Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

Figure 1 Controlled attenuation parameter distribution for different steatosis grades or body mass index levels. A: Controlled attenuation parameter distribution in patients with different steatosis grades (n = 152); B: CAP distribution in patients with different BMI levels (n = 152); C: CAP distribution in patients with BMI levels with either no steatosis or steatosis less than 5% (n = 63); D: CAP between NAFLD and CHB patients with the same degree of fatty deposition (n = 89). ¹Fisher’s exact test was used; ²No NAFLD patients in S0. CAP: Controlled attenuation parameter; BMI: Body mass index; NAFLD: Non-alcoholic fatty liver disease; CHB: Chronic hepatitis B.

Figure 2 Receiver operating characteristic curves. A: Receiver operating characteristic curve for controlled attenuation parameter in the diagnosis of hepatic steatosis ≥ 5%, ≥ 34% and ≥ 67%; B: Receiver operating characteristic curves and area under the curves (AUCs) between two steatosis grades. Se: sensitivity; Sp: specificity.